Dynamic Advisor Solutions LLC Boosts Holdings in Stryker Corporation $SYK

Dynamic Advisor Solutions LLC lifted its holdings in Stryker Corporation (NYSE:SYK) by 22.1% in the second quarter, HoldingsChannel reports. The firm owned 9,283 shares of the medical technology company’s stock after buying an additional 1,678 shares during the quarter. Dynamic Advisor Solutions LLC’s holdings in Stryker were worth $2,923,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in SYK. Baron Wealth Management LLC grew its holdings in Stryker by 17.8% during the 2nd quarter. Baron Wealth Management LLC now owns 1,658 shares of the medical technology company’s stock worth $522,000 after acquiring an additional 251 shares in the last quarter. GAMMA Investing LLC boosted its holdings in shares of Stryker by 42.5% in the 2nd quarter. GAMMA Investing LLC now owns 7,578 shares of the medical technology company’s stock valued at $2,386,000 after buying an additional 2,261 shares in the last quarter. Avior Wealth Management LLC boosted its stake in Stryker by 1.4% in the second quarter. Avior Wealth Management LLC now owns 7,353 shares of the medical technology company’s stock valued at $2,315,000 after acquiring an additional 98 shares in the last quarter. Canandaigua National Bank & Trust Co. purchased a new position in Stryker during the 2nd quarter worth approximately $2,168,000. Finally, Brighton Securities CORP. grew its position in shares of Stryker by 6.1% during the second quarter. Brighton Securities CORP. now owns 662 shares of the medical technology company’s stock worth $208,000 after acquiring an additional 38 shares during the last quarter. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Stryker

In other Stryker news, Director Ronda E. Stryker sold 310,000 shares of the stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the transaction, the director owned 1,924,880 shares of the company’s stock, valued at $601,005,282.40. This trade represents a 13.87% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Robert S. Fletcher sold 4,544 shares of the business’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the sale, the vice president directly owned 10,582 shares of the company’s stock, valued at approximately $3,247,298.34. This represents a 30.04% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 323,264 shares of company stock valued at $100,659,489. 4.60% of the stock is currently owned by insiders.

Analyst Ratings Changes

SYK has been the topic of several recent research reports. Sanford C. Bernstein set a $410.00 price target on Stryker in a research report on Friday, May 1st. Robert W. Baird set a $385.00 price target on shares of Stryker in a report on Friday, May 1st. Evercore set a $350.00 price objective on Stryker in a report on Monday, July 6th. Wall Street Zen upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Raymond James Financial set a $370.00 price target on Stryker in a report on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, Stryker presently has a consensus rating of “Moderate Buy” and a consensus target price of $386.28.

Stryker Price Performance

Shares of Stryker stock opened at $338.85 on Friday. The company has a current ratio of 2.16, a quick ratio of 1.33 and a debt-to-equity ratio of 0.59. Stryker Corporation has a twelve month low of $281.00 and a twelve month high of $396.86. The stock has a market capitalization of $129.97 billion, a P/E ratio of 35.11, a PEG ratio of 2.15 and a beta of 0.76. The business’s fifty day moving average price is $320.11 and its 200 day moving average price is $334.13.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share for the quarter, beating analysts’ consensus estimates of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The firm had revenue of $6.59 billion for the quarter, compared to analysts’ expectations of $6.58 billion. During the same period in the previous year, the company posted $3.13 earnings per share. Stryker’s revenue was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, research analysts anticipate that Stryker Corporation will post 15.02 earnings per share for the current year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be paid a dividend of $0.88 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.0%. Stryker’s dividend payout ratio (DPR) is currently 36.48%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.